PsyMed Ventures


PsyMed Ventures is a community-focused fund and syndicate that provides capital and operational support to companies working on mental and brain health. The firm focuses on frontier technologies — including psychedelics and novel compounds, neurotechnology/BCI, precision neuroscience, digital therapeutics, AI-driven approaches, and new biologic modalities — and describes its mission as aligning healing, responsibility, and profitability.

Industries

finance
financial-services
venture-capital-b37d

Nr. of Employees

small (1-50)


Portfolio

Described as a precision psychiatry drug development platform.

#Precision psychiatry drug development platform

Described as CRISPR for live biotherapeutics and bacterial products.

#CRISPR-based live biotherapeutics and bacterial products

Platform with a pipeline of 10+ programs for brain and mental health.

#Drug development platform for brain and mental health

Drug development platform focused on neurological and psychiatric disorders.

#Drug development platform for neurological and psychiatric disorders

Develops novel ketamine formulations for pain management and mental health disorders.

#Novel ketamine formulations

Microbiome therapeutics platform for neurological disease.

#Microbiome therapeutics for neurological disease

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.